Rhumbline Advisers Artivion, Inc. Transaction History
Rhumbline Advisers
- $109 Billion
- Q3 2024
A detailed history of Rhumbline Advisers transactions in Artivion, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 113,380 shares of AORT stock, worth $3.24 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
113,380
Previous 118,836
4.59%
Holding current value
$3.24 Million
Previous $3.05 Million
0.98%
% of portfolio
0.0%
Previous 0.0%
Shares
29 transactions
Others Institutions Holding AORT
# of Institutions
174Shares Held
35.8MCall Options Held
33KPut Options Held
900-
Black Rock Inc. New York, NY6.64MShares$189 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.8MShares$80 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY2.79MShares$79.8 Million1.94% of portfolio
-
Macquarie Group LTD Australia, C32.75MShares$78.4 Million0.08% of portfolio
-
Morgan Stanley New York, NY2.45MShares$70 Million0.0% of portfolio
About ARTIVION, INC.
- Ticker AORT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 40,316,100
- Market Cap $1.15B
- Description
- Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...